Cannabidiol for ASD Open Trial
NCT03900923
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
29
Enrollment
OTHER
Sponsor class
Conditions
ASD
Autism Spectrum Disorder
Interventions
DRUG:
98% pure CBD
Sponsor
NYU Langone Health